| Name | Title | Contact Details |
|---|
Precigen (Nasdaq: PGEN) is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in our core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Our technologies enable us to find innovative solutions for affordable biotherapeutics in a controlled manner. Precigen operates as an innovation engine progressing a preclinical and clinical pipeline of well-differentiated unique therapies toward clinical proof-of-concept and commercialization.
Edifice Health is a digital health spin-out company from a 10-year Stanford research in human immunology offering a novel metric of inflammatory health.
Egenomics is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Groton Biosystems is a Boxborough, MA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Ceregene is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.